Pacific Biosciences of California Inc
NASDAQ:PACB

Watchlist Manager
Pacific Biosciences of California Inc Logo
Pacific Biosciences of California Inc
NASDAQ:PACB
Watchlist
Price: 1.26 USD -6.67% Market Closed
Market Cap: $380.5m

During the last 3 months Pacific Biosciences of California Inc insiders have not bought any shares, and sold 1.2m USD worth of shares. The stock price has dropped by 26% over this period (open performance analysis).

The last transaction was made on Mar 3, 2026 by Henry Christian O , who sold 18.9k USD worth of PACB shares.

Last Transactions:
Van Oene Mark
$-9.8k
Farmer Michele
$-4.5k
Henry Christian O
$-18.9k
Van Oene Mark
$-89.8k
Farmer Michele
$-24.4k
Henry Christian O
$-229.5k
Van Oene Mark
Chief Operating Officer
$-204.5k
Farmer Michele
Chief Commercial Officer
$-55.5k
Henry Christian O
Chief Commercial Officer
$-522.9k
Van Oene Mark
$-35.2k
Farmer Michele
$-5.2k
Van Oene Mark
$-9.1k
Farmer Michele
$-4.2k
Henry Christian O
$-17.6k
Henry Christian O
$-488.1k
Farmer Michele
$-45.7k
Van Oene Mark
$-189.3k
Van Oene Mark
$-70k
Kim Susan G.
$-34.1k
Henry Christian O
$-172.7k
Eidel Jeff
$-42.6k
Van Oene Mark
$-63.2k
Farmer Michele
$-10.7k
Meline David W
$+176.2k
Henry Christian O
$-69.1k
Kim Susan G.
$-25.7k
Van Oene Mark
$-44.7k
Farmer Michele
$-14.5k
Henry Christian O
$-10.4k
Kim Susan G.
$-4.4k
Farmer Michele
$-45.1k
Henry Christian O
$-470.9k
View All Transactions

During the last 3 months Pacific Biosciences of California Inc insiders have not bought any shares, and sold 1.2m USD worth of shares. The stock price has dropped by 26% over this period (open performance analysis).

The last transaction was made on Mar 3, 2026 by Henry Christian O , who sold 18.9k USD worth of PACB shares.

Sold
0-3
months
1.2m USD
3
3-6
months
0 USD
0
6-9
months
35.2k USD
1
9-12
months
5.2k USD
1
Bought
0-3
months
0
0 USD
3-6
months
No Insider Transactions
0
0 USD
6-9
months
0
0 USD
9-12
months
0
0 USD

Pacific Biosciences of California Inc
Insider Trading Chart

Pacific Biosciences of California Inc
Insiders Performance

1 Week Later 1 Month Later 3 Months Later 6 Months Later 1 Year Later
Average Return
Median Return
Win Rate

Pacific Biosciences of California Inc
Last Insider Transactions

Global
Insiders Monitor

Pacific Biosciences of California Inc
Glance View

Pacific Biosciences of California, Inc. engages in the development, manufacture and sale of an integrated platform for genetic analysis. The company is headquartered in Menlo Park, California and currently employs 728 full-time employees. The company went IPO on 2010-10-27. The firm designs, develops and manufactures advanced sequencing solutions to help scientists and clinical researchers resolve genetically complex problems. The firm has developed its Single Molecule, Real-Time (SMRT) technology, which enables single molecule, real-time detection of nucleic acid sequences, to address many of the limitations of previous sequencing technologies. The Company’s products include Sequel, Sequel II and Sequel IIe instruments and SMRT Cell 8M, which together can sequence up to approximately eight million deoxyribonucleic acid (DNA) molecules simultaneously, and the previous generation Sequel instrument and Sequel SMRT Cell 1M, which together conduct, monitor, and analyze single molecule biochemical reactions in real time. The firm's Sequel IIe System increases computational capacity and is designed to enable customers to generate PacBio HiFi reads.

PACB Intrinsic Value
2.71 USD
Undervaluation 53%
Intrinsic Value
Price

What is Insider Trading?

Insider trading refers to the buying or selling of a company’s stock by individuals with access to non-public, material information about the company.

While legal insider trading occurs when insiders follow disclosure rules, illegal insider trading involves trading based on confidential information and is prohibited by law.

Why is Insider Trading Important?

It isn't a coincidence that corporate executives seem to always buy at the right times. After all, they have access to every bit of company information you could ever want.

However, the fact that company executives have unique insights doesn't mean that individual investors are always left in the dark. Insider trading data is out there for all who want to use it.

Peter Lynch

Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett